
Federica Fogacci
@federicafogacci
@Unibo & Brisighella Heart Study Group | SoMe Ambassador and Young Fellow of @society_eas | SoMe Editor of @ATHjournal
ID: 1255405463300169729
29-04-2020 07:56:14
1,1K Tweet
1,1K Followers
1,1K Following


🔥🔥🔥 #ESCPrev2025 Satellite symposium on “Novel Therapies for Managing Patients with #CardioKidneyMetabolic syndrome & #HeartFailure” Together with Riccardo M. Inciardi, MD, PhD & Cristina Gavina is now available for your view on PACE-CME Do not miss it! : bit.ly/3GfTT8Q European Society of Cardiology



So happy to see Naif ALGhasab| نايف الغصاب’s new study on dextrocardia published ✨ The largest cohort in the region — with valuable insights into survival and congenital anomalies. Grateful to see this kind of work come to light #CvPrev 📖 j-saudi-heart.com/jsha/vol37/iss… Università di Bologna Arrigo F.G. Cicero


Here is a useful chart of reference ranges for those using the NMR derived Lipoprotein Insulin Resistance Score (LP-IR Score). These metrics do not apply to such metrics derived by Ion Mobility Transfer separation of lipoproteins (Quest methodology) National Lipid Association European Atherosclerosis Society


Have you checked out the latest #AtheroTalk episode yet? 🎙️ It’s out now and worth a listen! European Atherosclerosis Society #academic #podcast 🎧 Spotify: open.spotify.com/episode/5X2j1X…



Super excited to be selected for the first IAS Inflammation Academy 🌟 Looking forward to learning, sharing ideas, and being inspired by amazing mentors and peers International Atherosclerosis Society (IAS) #CvPrev Università di Bologna #EASSoMe European Atherosclerosis Society 🔗 athero.org/ias-inflammati…

Hot off the press 🔥 The #EAS2025 abstracts have just been published in Atherosclerosis! Check out the cutting-edge research shaping the future of lipid & cardiovascular science 👉 atherosclerosis-journal.com/issue/S0021-91… 🌟 #EASSoMe European Atherosclerosis Society


Our 🆕 review is out in the European Journal of Internal Medicine! In the first part of this series, we explore the dual nature of UA: from antioxidant to pro-inflamm mediator driving endothelial dysf, kidney damage & 🫀 risk. We also discuss the need for personalized targets 📖 doi.org/10.1016/j.ejim…
